Tokyo Tape
Sign in
← Sundrug

Quarterly report · Q1

9989.TEDINET S100ROPZ
Period2023-04-01 → 2023-06-30
Filed2023-08-14
StandardJapan GAAP
ConsolidatedYes
Data checks12 of 12 passed
Key figures · 34
MetricValuePeriodScopeSource row
Revenue¥182.1bn2023-04-01 → 2023-06-30Cons.Net sales
Revenue¥690.5bn2022-04-01 → 2023-03-31Cons.Net sales (5-year summary)
Revenue¥166.5bn2022-04-01 → 2022-06-30Cons.Net sales
Operating income¥9.9bn2023-04-01 → 2023-06-30Cons.Operating income
Operating income¥9.1bn2022-04-01 → 2022-06-30Cons.Operating income
Ordinary income¥10.1bn2023-04-01 → 2023-06-30Cons.Ordinary income
Ordinary income¥38.1bn2022-04-01 → 2023-03-31Cons.Ordinary income loss (5-year summary)
Ordinary income¥9.2bn2022-04-01 → 2022-06-30Cons.Ordinary income
Profit before tax¥10.1bn2023-04-01 → 2023-06-30Cons.Income before income taxes
Profit before tax¥9.2bn2022-04-01 → 2022-06-30Cons.Income before income taxes
Net income (owners)¥6.9bn2023-04-01 → 2023-06-30Cons.Profit loss attributable to owners of parent
Net income (owners)¥25.7bn2022-04-01 → 2023-03-31Cons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)¥6.3bn2022-04-01 → 2022-06-30Cons.Profit loss attributable to owners of parent
Net income¥6.9bn2023-04-01 → 2023-06-30Cons.Profit loss
Net income¥6.3bn2022-04-01 → 2022-06-30Cons.Profit loss
Total assets¥353.5bnat 2023-06-30Cons.Assets
Total assets¥360.7bnat 2023-03-31Cons.Assets
Total assets¥326.3bnat 2022-06-30Cons.Total assets (5-year summary)
Total liabilities¥116.1bnat 2023-06-30Cons.Liabilities
Total liabilities¥124.3bnat 2023-03-31Cons.Liabilities
Net assets / equity¥237.4bnat 2023-06-30Cons.Net assets
Net assets / equity¥236.3bnat 2023-03-31Cons.Net assets
Net assets / equity¥222.7bnat 2022-06-30Cons.Net assets (5-year summary)
Cash and deposits¥68.8bnat 2023-06-30Cons.Cash and deposits
Cash and deposits¥80.9bnat 2023-03-31Cons.Cash and deposits
EPS (basic)¥59.022023-04-01 → 2023-06-30Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥219.832022-04-01 → 2023-03-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥53.872022-04-01 → 2022-06-30Cons.Basic earnings loss per share (5-year summary)
EPS (diluted)¥59.012023-04-01 → 2023-06-30Cons.Diluted earnings per share (5-year summary)
EPS (diluted)¥219.822022-04-01 → 2023-03-31Cons.Diluted earnings per share (5-year summary)
EPS (diluted)¥53.862022-04-01 → 2022-06-30Cons.Diluted earnings per share (5-year summary)
Equity ratio67.1%at 2023-06-30Cons.Equity to asset ratio (5-year summary)
Equity ratio65.5%at 2023-03-31Cons.Equity to asset ratio (5-year summary)
Equity ratio68.2%at 2022-06-30Cons.Equity to asset ratio (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 28
SegmentItemPeriodValue
Reconciling Itemsreconcilingrevenue2023-04-01 → 2023-06-30−¥13.1bn
Reconciling Itemsreconcilingrevenue intersegment2023-04-01 → 2023-06-30−¥13.1bn
jpcrp040300-q1r_E03226-000Discount Storereportable segmentrevenue2023-04-01 → 2023-06-30¥75.9bn
jpcrp040300-q1r_E03226-000Discount Storereportable segmentrevenue external2023-04-01 → 2023-06-30¥75.9bn
jpcrp040300-q1r_E03226-000Discount Storereportable segmentrevenue intersegment2023-04-01 → 2023-06-30¥2m
jpcrp040300-q1r_E03226-000Discount Storereportable segmentsegment profit2023-04-01 → 2023-06-30¥3.9bn
jpcrp040300-q1r_E03226-000Drug Storereportable segmentrevenue2023-04-01 → 2023-06-30¥119.3bn
jpcrp040300-q1r_E03226-000Drug Storereportable segmentrevenue external2023-04-01 → 2023-06-30¥106.2bn
jpcrp040300-q1r_E03226-000Drug Storereportable segmentrevenue intersegment2023-04-01 → 2023-06-30¥13.1bn
jpcrp040300-q1r_E03226-000Drug Storereportable segmentsegment profit2023-04-01 → 2023-06-30¥6.0bn
Total Of Reportable Segments And Otherssegment totalrevenue2023-04-01 → 2023-06-30¥195.3bn
Total Of Reportable Segments And Otherssegment totalrevenue external2023-04-01 → 2023-06-30¥182.1bn
Total Of Reportable Segments And Otherssegment totalrevenue intersegment2023-04-01 → 2023-06-30¥13.1bn
Total Of Reportable Segments And Otherssegment totalsegment profit2023-04-01 → 2023-06-30¥9.9bn
Reconciling Itemsreconcilingrevenue2022-04-01 → 2022-06-30−¥12.4bn
Reconciling Itemsreconcilingrevenue intersegment2022-04-01 → 2022-06-30−¥12.4bn
jpcrp040300-q1r_E03226-000Discount Storereportable segmentrevenue2022-04-01 → 2022-06-30¥70.4bn
jpcrp040300-q1r_E03226-000Discount Storereportable segmentrevenue external2022-04-01 → 2022-06-30¥70.4bn
jpcrp040300-q1r_E03226-000Discount Storereportable segmentrevenue intersegment2022-04-01 → 2022-06-30¥3m
jpcrp040300-q1r_E03226-000Discount Storereportable segmentsegment profit2022-04-01 → 2022-06-30¥3.4bn
jpcrp040300-q1r_E03226-000Drug Storereportable segmentrevenue2022-04-01 → 2022-06-30¥108.5bn
jpcrp040300-q1r_E03226-000Drug Storereportable segmentrevenue external2022-04-01 → 2022-06-30¥96.1bn
jpcrp040300-q1r_E03226-000Drug Storereportable segmentrevenue intersegment2022-04-01 → 2022-06-30¥12.4bn
jpcrp040300-q1r_E03226-000Drug Storereportable segmentsegment profit2022-04-01 → 2022-06-30¥5.6bn
Total Of Reportable Segments And Otherssegment totalrevenue2022-04-01 → 2022-06-30¥178.8bn
Total Of Reportable Segments And Otherssegment totalrevenue external2022-04-01 → 2022-06-30¥166.5bn
Total Of Reportable Segments And Otherssegment totalrevenue intersegment2022-04-01 → 2022-06-30¥12.4bn
Total Of Reportable Segments And Otherssegment totalsegment profit2022-04-01 → 2022-06-30¥9.1bn

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 333
ItemContextValueUnit
Dividends income noiPrior1YTDDuration3000000JPY
Dividends income noiCurrentYTDDuration3000000JPY
Gain on donation of noncurrent assets noiPrior1YTDDuration40000000JPY
Gain on donation of noncurrent assets noiCurrentYTDDuration88000000JPY
Other noiPrior1YTDDuration45000000JPY
Other noiCurrentYTDDuration93000000JPY
Non operating incomePrior1YTDDuration112000000JPY
Non operating incomeCurrentYTDDuration214000000JPY
Interest expenses noePrior1YTDDuration2000000JPY
Interest expenses noeCurrentYTDDuration7000000JPY
Other noePrior1YTDDuration0JPY
Other noeCurrentYTDDuration3000000JPY
Non operating expensesPrior1YTDDuration2000000JPY
Non operating expensesCurrentYTDDuration10000000JPY
Ordinary incomePrior1YTDDuration9169000000JPY
Ordinary incomeCurrentYTDDuration10103000000JPY
Gain on sales of noncurrent assets eiPrior1YTDDuration0JPY
Gain on sales of noncurrent assets eiCurrentYTDDuration0JPY
Penalty income eiPrior1YTDDuration－JPY
Penalty income eiCurrentYTDDuration131000000JPY
Other eiPrior1YTDDuration－JPY
Other eiCurrentYTDDuration7000000JPY
Extraordinary incomePrior1YTDDuration0JPY
Extraordinary incomeCurrentYTDDuration138000000JPY
Impairment loss elPrior1YTDDuration－JPY
Impairment loss elCurrentYTDDuration34000000JPY
Loss on retirement of noncurrent assets elPrior1YTDDuration13000000JPY
Loss on retirement of noncurrent assets elCurrentYTDDuration38000000JPY
Loss on disaster elPrior1YTDDuration0JPY
Loss on disaster elCurrentYTDDuration80000000JPY
Other elPrior1YTDDuration－JPY
Other elCurrentYTDDuration24000000JPY
Extraordinary lossPrior1YTDDuration13000000JPY
Extraordinary lossCurrentYTDDuration177000000JPY
Income before income taxesPrior1YTDDuration9155000000JPY
Income before income taxesCurrentYTDDuration10064000000JPY
Income taxesPrior1YTDDuration2856000000JPY
Income taxesCurrentYTDDuration3164000000JPY
Profit lossPrior1YTDDuration6298000000JPY
Profit lossCurrentYTDDuration6900000000JPY
Profit loss attributable to non controlling interestsPrior1YTDDuration－JPY
Profit loss attributable to non controlling interestsCurrentYTDDuration－JPY
Profit loss attributable to owners of parentPrior1YTDDuration6298000000JPY
Profit loss attributable to owners of parentCurrentYTDDuration6900000000JPY
Profit lossPrior1YTDDuration6298000000JPY
Profit lossCurrentYTDDuration6900000000JPY
Valuation difference on available for sale securities net of tax ociPrior1YTDDuration5000000JPY
Valuation difference on available for sale securities net of tax ociCurrentYTDDuration15000000JPY
Remeasurements of defined benefit plans net of tax ociPrior1YTDDuration1000000JPY
Remeasurements of defined benefit plans net of tax ociCurrentYTDDuration4000000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 12 of 12 passed
balance sheet identityconsolidated 2023-03-31pass
balance sheet identityconsolidated 2023-06-30pass
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2023-03-31pass
statement vs summary · net assetsconsolidated 2023-06-30pass
statement vs summary · net income attributable to parentconsolidated 2022-04-01/2022-06-30pass
statement vs summary · net income attributable to parentconsolidated 2023-04-01/2023-06-30pass
statement vs summary · revenueconsolidated 2022-04-01/2022-06-30pass
statement vs summary · revenueconsolidated 2023-04-01/2023-06-30pass
statement vs summary · total assetsconsolidated 2023-03-31pass
statement vs summary · total assetsconsolidated 2023-06-30pass